Health Technology Assessment of Vaccination: Strategies, Public Health and Values

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 180

Special Issue Editors


E-Mail Website
Guest Editor
Unit of Global Health, Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, 9713 GZ Groningen, The Netherlands
Interests: vaccines; global health; health technology assessment; cost-effectiveness; health economics
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Unit of Global Health, Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, 9713 GZ Groningen, The Netherlands
Interests: health care sciences and services; health policy and services; public; environmental and occupational health

E-Mail Website
Guest Editor
Unit of Global Health, Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, 9713 GZ Groningen, The Netherlands
Interests: health economics; health policy; health outcomes; epidemiology; prevention; health systems
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Health Technology Assessment (HTA) has an increasing role worldwide in the accessibility and use of vaccines. This Special Issue aims to bring together the views and interests of different stakeholders to enhance mutual understanding. The topics to be addressed include time-to-population access vaccine studies, cost-effectiveness analyses, real-world monitoring of vaccine performances, and guidelines for adequate vaccine HTA evaluations.

Specific aims include a better understanding of vaccine hesitancy, long periods of population access, roles of cost-effectiveness and budgets, views of patient groups, and the advantages of vaccines. Original research articles and reviews, within the journal’s scope, are welcome for submission, focusing on themes such as the value of vaccines, the time it takes for innovative vaccines to reach patients, cost-effectiveness assessments, real-world data analyses on vaccines' properties, and overcoming vaccine hesitancy to increase coverage.

We look forward to receiving valuable contributions.

Prof. Dr. Maarten J. Postma
Dr. Jurjen Van der Schans
Prof. Dr. Cornelis Boersma
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • health technology assessment
  • population access vaccine studies
  • vaccination cost-effectiveness
  • vaccine hesitancy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop